vial_slope
TL3 Regular · Ferrara, IT
Clinician. Posts general information only, and says so every time.
Joined 8 December 2024 · last posted 11h · groups: clinicians
163 posts, newest first. Showing up to 150.
-
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #7 · Analytics › Home & field testing · 27 Jul 2026 · 23 likes Coming back to post #5, because the follow-up matters more than the original answer. False positives and false negatives: no test has 100% sensitivity and 100%…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #102 · Practice › Administration · 26 Jul 2026 · 27 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Packaging that arrived damaged: documenting it properly Replied, post #49 · Sourcing › Logistics · 25 Jul 2026 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
What is genuinely unknown about long-term amylin agonism Replied, post #52 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2026 · 0 likes This follows post #49 rather than contradicting it. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #80 · Access › Insurance & coverage · 17 Jul 2026 · 31 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Follow-up: Reading an interaction checker output critically Replied, post #46 · Practice › Interactions · 14 Jul 2026 · 2 likes post #45 is right about the mechanism and I think understates the practical bit. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
How shortages have affected compounding permissions Replied, post #35 · Access › Shortages · 13 Jul 2026 · 18 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #45 · Practice › Administration · 13 Jul 2026 · 0 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #54 · Clinical › Comorbidities · 13 Jul 2026 · 21 likes This follows post #51 rather than contradicting it. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #58 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 6 likes On post #54 — agreed on the reasoning, with one qualification. On integration: where the baseline is drawn matters more than most people realise. On a clean…
-
Spreadsheets: an appreciation — what changed since Replied, post #94 · Lounge › Off topic · 8 Jul 2026 · 0 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #28 · Compounds › Secretagogues & GH axis · 7 Jul 2026 · 33 likes post #27 answers the question as asked. The question underneath it is different. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone…
-
Submitting a sample: the process end to end Replied, post #60 · Sourcing › Independent verification · 5 Jul 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Private prescribing in the UK: what is actually involved Replied, post #56 · Regional › UK & Ireland · 5 Jul 2026 · 22 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #64 · Analytics › Home & field testing · 4 Jul 2026 · 9 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Reading a home test result without over-claiming Replied, post #94 · Analytics › Home & field testing · 26 Jun 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
A 40-week log with the measurement method stated — what changed since Replied, post #9 · Outcomes › Progress reports · 23 Jun 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #33 · Start Here › Welcome · 20 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #34 · Research Methods › Statistics · 19 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: The storage lookup and where its data comes from Replied, post #33 · Data & Tools › Calculators · 19 Jun 2026 · 0 likes Worth separating two things that post #29 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #74 · Start Here › Welcome · 13 Jun 2026 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Racemisation and why it is invisible to a mass measurement Replied, post #85 · Analytics › Impurities & related substances · 13 Jun 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Tracking intake honestly when appetite is absent Replied, post #55 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 2 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Injecting into an area that has become firm: why not to Replied, post #22 · Practice › Administration · 6 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Shoulders, tangent skims, and defensible integration Replied, post #6 · Analytics › HPLC & UHPLC · 5 Jun 2026 · 1 like Worth separating two things that post #2 runs together. System suitability testing: injections run before and during the sample run to establish whether the instrument,…
-
[2026 update] Travelling with an injectable: documentation and practicalities Started this topic · Access › International · 4 Jun 2026 · 4 likes Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #16 · Sourcing › Red flags · 3 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #67 · Practice › Reconstitution · 1 Jun 2026 · 0 likes I read post #65 twice before replying, because I had assumed the opposite. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #28 · Clinical › Prescriber conversations · 29 May 2026 · 15 likes post #27 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #49 · Safety › Contraindications · 24 May 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #9 · Pharmacology › Pharmacokinetics · 23 May 2026 · 18 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #60 · Compounds › Semaglutide · 20 May 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #52 · Practice › Reconstitution · 20 May 2026 · 10 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Follow-up: Search filters: what is missing Replied, post #97 · Meta › Site feedback · 9 May 2026 · 0 likes I read post #95 twice before replying, because I had assumed the opposite. Bugs and friction: the parts of the site that do not work the way you expected. Report them…
-
Why this subcategory is stricter about sourcing than most Replied, post #27 · Compounds › Secretagogues & GH axis · 8 May 2026 · 16 likes This follows post #24 rather than contradicting it. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #56 · Sourcing › Logistics · 30 Apr 2026 · 20 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #10 · Analytics › Home & field testing · 28 Apr 2026 · 7 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #124 · Practice › Reconstitution · 25 Apr 2026 · 0 likes On post #120 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #110 · Practice › Reconstitution · 24 Apr 2026 · 23 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #53 · Evidence › Trials · 21 Apr 2026 · 0 likes I read post #51 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #152 · Access › Pricing · 19 Apr 2026 · 16 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #60 · Data & Tools › Calculators · 9 Apr 2026 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Publication bias detection and its low power — does this still hold? Replied, post #22 · Evidence › Meta-analyses · 7 Apr 2026 · 3 likes Picking up post #19: that is the part I would want checked first. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #26 · Evidence › Trials · 30 Mar 2026 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Does a peptide degrade silently, with no visual change? Replied, post #3 · Practice › Storage & stability · 30 Mar 2026 · 11 likes I read the opening post twice before replying, because I had assumed the opposite. Visual inspection: if a solution is visibly cloudy, discoloured, or contains…
-
Grapefruit: why this class is not the class that cares Replied, post #80 · Practice › Interactions · 25 Mar 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Citation sweep results: how many references did not say what was claimed Replied, post #65 · Meta › Wiki maintenance · 23 Mar 2026 · 0 likes post #64 answers the question as asked. The question underneath it is different. Authority: if you think a page needs input from someone with specific expertise,…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #52 · Practice › Storage & stability · 1 Mar 2026 · 0 likes post #51 answers the question as asked. The question underneath it is different. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #55 · Data & Tools › Calculators · 23 Feb 2026 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #49 · Practice › Side effects · 23 Feb 2026 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #62 · Practice › Dosing & titration · 21 Feb 2026 · 11 likes Picking up post #59: that is the part I would want checked first. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #47 · Regional › UK & Ireland · 19 Feb 2026 · 0 likes post #46 answers the question as asked. The question underneath it is different. Cross-border arrangements: some people source from other EU countries. Rules on import…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #10 · Practice › Dosing & titration · 15 Feb 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #16 · Analytics › Mass spectrometry · 12 Feb 2026 · 3 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #30 · Research Methods › N-of-1 designs · 10 Feb 2026 · 3 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #35 · Start Here › Welcome · 26 Jan 2026 · 24 likes This follows post #32 rather than contradicting it. Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than…
-
When to stop reading forums, including this one Replied, post #77 · Wellbeing › Mental health · 17 Jan 2026 · 0 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
A partial dose because the pen emptied mid-injection Replied, post #32 · Practice › Administration · 8 Jan 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What to include when your question involves a chromatogram Replied, post #22 · Start Here › How to Ask · 5 Jan 2026 · 11 likes post #21 is right about the mechanism and I think understates the practical bit. Lab result questions: state the result, the reference interval, and what else is on the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #14 · Practice › Side effects · 2 Jan 2026 · 22 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Hepatic steatosis: what the MASH trial evidence supports — one year on Replied, post #2 · marked as the solution · Clinical › Comorbidities · 26 Dec 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #5 · Practice › Storage & stability · 22 Dec 2025 · 14 likes Picking up post #2: that is the part I would want checked first. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the…
-
Reading SURMOUNT-1 without the press release Replied, post #102 · Compounds › Tirzepatide · 15 Dec 2025 · 20 likes post #101 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Moderation log format change Replied, post #14 · Meta › Announcements · 13 Dec 2025 · 2 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #38 · Documentation › Doc review · 10 Dec 2025 · 0 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #107 · Compounds › Other compounds · 26 Nov 2025 · 0 likes On post #103 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the…
-
Persistent vomiting and the threshold for seeking help Replied, post #73 · Safety › Adverse events · 21 Nov 2025 · 6 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Why "add 2 mL" is not an instruction Replied, post #7 · Practice › Reconstitution · 11 Nov 2025 · 9 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Shoulders, tangent skims, and defensible integration — the long version Started this topic · Analytics › HPLC & UHPLC · 26 Oct 2025 · 17 likes Shoulders, tangent skims, and defensible integration — the long version Writing it up because I had to work it out twice and would rather nobody else did. Posting the…
-
Payment mechanics and the recovery options that do not exist Replied, post #84 · Sourcing › Payments · 22 Oct 2025 · 8 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #88 · Start Here › Welcome · 20 Oct 2025 · 16 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #38 · Clinical › Special populations · 20 Oct 2025 · 6 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #21 · Compounds › Tirzepatide · 19 Oct 2025 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Lyophilisation and why the cake looks the way it does Replied, post #17 · Pharmacology › Formulation chemistry · 22 Sep 2025 · 1 like On post #13 — agreed on the reasoning, with one qualification. Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #12 · Analytics › Method validation · 10 Sep 2025 · 18 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
What this community means by "a source", in practical terms Replied, post #106 · Start Here › Welcome · 9 Sep 2025 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #19 · Data & Tools › Datasets · 7 Sep 2025 · 1 like Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #16 · Evidence › Journal club · 5 Sep 2025 · 8 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #19 · Practice › Storage & stability · 31 Aug 2025 · 32 likes post #18 is right about the mechanism and I think understates the practical bit. Container choice matters: the material of the vial, the rubber closure, the fill volume…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #39 · Compounds › Tirzepatide · 30 Aug 2025 · 7 likes This follows post #36 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Are there stupid questions here? A staff answer, at length Replied, post #123 · Start Here › Welcome · 28 Aug 2025 · 0 likes post #122 answers the question as asked. The question underneath it is different. Your introduction is well framed. You have given enough context that people can…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #38 · Analytics › HPLC & UHPLC · 26 Aug 2025 · 14 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #51 · Practice › Side effects · 24 Aug 2025 · 31 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #8 · Analytics › Method validation · 20 Aug 2025 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #53 · Analytics › Home & field testing · 19 Aug 2025 · 4 likes Worth separating two things that post #49 runs together. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #82 · Sourcing › Regulatory · 17 Aug 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #50 · Practice › Dosing & titration · 17 Aug 2025 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Insurance and replacement policies, compared — the long version Replied, post #6 · Sourcing › Logistics · 15 Aug 2025 · 14 likes Picking up post #3: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Immortal time bias in a claims-database study Replied, post #21 · Evidence › Study critique · 15 Aug 2025 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Are there stupid questions here? A staff answer, at length Replied, post #54 · Start Here › Welcome · 9 Aug 2025 · 6 likes I read post #52 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Travel coolers and how long they really hold Replied, post #57 · Devices › Cold chain · 5 Aug 2025 · 0 likes Coming back to post #55, because the follow-up matters more than the original answer. Shipment during summer or to hot climates: consider shipping to a cold-storage…
-
Temperature loggers worth the money — the long version Replied, post #20 · Devices › Cold chain · 4 Aug 2025 · 8 likes post #19 is right about the mechanism and I think understates the practical bit. Travel with medication: carrying a vial across borders requires planning if…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #96 · Compounds › Semaglutide · 31 Jul 2025 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #4 · marked as the solution · Sourcing › Vendor reports · 31 Jul 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #12 · Sourcing › Red flags · 29 Jul 2025 · 0 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Titles that describe the question, not the situation Replied, post #52 · Start Here › How to Ask · 20 Jul 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #68 · Compounds › Repair & healing peptides · 14 Jul 2025 · 17 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #46 · Sourcing › Regulatory · 10 Jul 2025 · 0 likes I read post #44 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #48 · Devices › Cold chain · 9 Jul 2025 · 13 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
An emergency department visit, described afterwards Replied, post #36 · Safety › Adverse events · 29 Jun 2025 · 3 likes I read post #34 twice before replying, because I had assumed the opposite. Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #54 · Compounds › Oral incretins · 26 Jun 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Asking about a compound your prescriber has not heard of Replied, post #74 · Clinical › Prescriber conversations · 23 Jun 2025 · 11 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Half-life, steady state, and accumulation worked through Replied, post #95 · Pharmacology › Pharmacokinetics · 10 Jun 2025 · 0 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #133 · Evidence › Journal club · 8 Jun 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #128 · Practice › Reconstitution · 7 Jun 2025 · 0 likes This follows post #125 rather than contradicting it. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration…
-
Half-life, steady state, and accumulation worked through Replied, post #76 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 8 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Antibiotics and a course of something with delayed emptying Replied, post #57 · Practice › Interactions · 4 Jun 2025 · 0 likes post #56 answers the question as asked. The question underneath it is different. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and…
-
Triple agonism: additive, synergistic, or neither? Replied, post #52 · Compounds › Retatrutide · 1 Jun 2025 · 12 likes Coming back to post #50, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #24 · Compounds › Repair & healing peptides · 27 May 2025 · 0 likes Picking up post #21: that is the part I would want checked first. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
-
A supplier that answers analytical questions with restated claims Replied, post #84 · Sourcing › Red flags · 26 May 2025 · 25 likes Worth separating two things that post #80 runs together. Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #29 · Evidence › Trials · 22 May 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #49 · Sourcing › Independent verification · 5 May 2025 · 12 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Transit times by route, from a logged dataset — the long version Replied, post #88 · Sourcing › Logistics · 30 Apr 2025 · 0 likes I read post #86 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Requesting a translation of an existing page Replied, post #13 · Documentation › Wiki requests · 30 Apr 2025 · 9 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
A page that has drifted out of date and needs a maintainer Replied, post #92 · Documentation › Wiki requests · 20 Apr 2025 · 14 likes post #91 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #50 · Evidence › Journal club · 19 Apr 2025 · 5 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #32 · Compounds › Repair & healing peptides · 9 Apr 2025 · 5 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
A supplier that answers analytical questions with restated claims Replied, post #48 · Sourcing › Red flags · 30 Mar 2025 · 14 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #31 · Compounds › Tirzepatide · 27 Mar 2025 · 32 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Excipient function in a licensed injectable Started this topic · Pharmacology › Formulation chemistry · 23 Mar 2025 · 26 likes Excipient function in a licensed injectable Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know…
-
Antibiotics and a course of something with delayed emptying Replied, post #8 · Practice › Interactions · 23 Mar 2025 · 3 likes post #7 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
About the Secretagogues & GH axis category Replied, post #4 · Compounds › Secretagogues & GH axis · 20 Mar 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Consistent declarations and why they matter more than clever ones Replied, post #158 · Sourcing › Logistics · 10 Mar 2025 · 10 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #44 · Documentation › Doc review · 7 Mar 2025 · 27 likes I read post #42 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #56 · Analytics › COA interpretation · 7 Mar 2025 · 21 likes post #55 answers the question as asked. The question underneath it is different. Counter-ion form is crucial: peptides are isolated as salts, most often…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #164 · Sourcing › Regulatory · 6 Mar 2025 · 1 like I read post #162 twice before replying, because I had assumed the opposite. Off-label use and medical practice: clinicians can prescribe approved medications off-label…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #151 · Sourcing › Regulatory · 6 Mar 2025 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #31 · Documentation › Doc review · 22 Feb 2025 · 2 likes This follows post #28 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #9 · Wellbeing › Mental health · 21 Feb 2025 · 0 likes This follows post #6 rather than contradicting it. Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #90 · Data & Tools › Calculators · 14 Feb 2025 · 26 likes post #89 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Canadian access and provincial variation Replied, post #78 · Regional › North America · 10 Feb 2025 · 0 likes Picking up post #75: that is the part I would want checked first. Provincial formularies in Canada are published and are the correct source for coverage information.…
-
An orphaned page with no inbound links Replied, post #6 · Meta › Wiki maintenance · 5 Feb 2025 · 4 likes Picking up post #3: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Follow-up: Why this community will not facilitate a group purchase Replied, post #3 · Sourcing › Payments · 26 Jan 2025 · 4 likes I read the opening post twice before replying, because I had assumed the opposite. Recurring billing: if a supplier sets up recurring billing by default, understanding…
-
Preservatives: function, testing, and limits Replied, post #3 · Pharmacology › Formulation chemistry · 17 Jan 2025 · 0 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #63 · Compounds › Other compounds · 13 Jan 2025 · 23 likes Worth separating two things that post #59 runs together. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds…
-
[2026 update] New subcategory: rationale and scope Replied, post #128 · Meta › Announcements · 7 Jan 2025 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #19 · Analytics › Mass spectrometry · 5 Jan 2025 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #9 · Analytics › Mass spectrometry · 4 Jan 2025 · 23 likes I read post #7 twice before replying, because I had assumed the opposite. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #5 · Data & Tools › Calculators · 28 Dec 2024 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #47 · Sourcing › Regulatory · 19 Dec 2024 · 3 likes This follows post #44 rather than contradicting it. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It…
-
Building a sensible monitoring schedule with your prescriber Replied, post #22 · Clinical › Bloodwork · 19 Dec 2024 · 22 likes This follows post #19 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Coming back to: When to suspect the method rather than the sample Replied, post #70 · Analytics › Method validation · 14 Dec 2024 · 12 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #139 · Analytics › COA interpretation · 4 Dec 2024 · 0 likes Worth separating two things that post #135 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #74 · Analytics › Method validation · 16 Nov 2024 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
US compounding rules and how they changed Replied, post #68 · Regional › North America · 11 Nov 2024 · 22 likes post #67 answers the question as asked. The question underneath it is different. Prior authorisation, step therapy, and exclusion of weight-management indications from…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #7 · Devices › Cold chain · 7 Nov 2024 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #122 · Clinical › Comorbidities · 28 Oct 2024 · 0 likes This follows post #119 rather than contradicting it. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and…
-
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Started this topic · Practice › Dosing & titration · 27 Oct 2024 · 10 likes Escalating every six weeks instead of four: what I observed over eight months — setting out what I have, and where I think it stops being reliable. A question about…
-
US compounding rules and how they changed Replied, post #24 · Regional › North America · 14 Oct 2024 · 1 like post #23 answers the question as asked. The question underneath it is different. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #73 · Clinical › Bloodwork · 2 Oct 2024 · 13 likes Picking up post #70: that is the part I would want checked first. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…